Organogenesis Holdings (ORGO) EBIAT (2017 - 2025)
Historic EBIAT for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.
- Organogenesis Holdings' EBIAT rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 11361.79%. This contributed to the annual value of $861000.0 for FY2024, which is 8258.85% down from last year.
- According to the latest figures from Q3 2025, Organogenesis Holdings' EBIAT is $21.6 million, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' EBIAT ranged from a high of $51.0 million in Q4 2021 and a low of -$18.8 million during Q1 2025
- Moreover, its 5-year median value for EBIAT was $5.3 million (2023), whereas its average is $5.7 million.
- Its EBIAT has fluctuated over the past 5 years, first surged by 145088.03% in 2024, then tumbled by 79728.57% in 2025.
- Organogenesis Holdings' EBIAT (Quarter) stood at $51.0 million in 2021, then crashed by 85.32% to $7.5 million in 2022, then crashed by 107.59% to -$568000.0 in 2023, then soared by 1450.88% to $7.7 million in 2024, then skyrocketed by 181.08% to $21.6 million in 2025.
- Its EBIAT stands at $21.6 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$18.8 million for Q1 2025.